SITC IMMUNO-ONCOLOGY SPRING WORKSHOPS - MARK YOUR CALENDARS!
Mark your calendars to attend SITC's spring workshops, to be held in San Francisco, CA. Registration will open soon.
Cancer Immune Responsiveness Workshop – May 14-15, 2018
This workshop promises to be a dynamic and lively opportunity to help determine which questions in cancer cell biology must be answered in order to understand patterns of immune interaction between the host and cancers of different ontology. Topics slated for discussion include the role of the host's genetic background and/or environmental modifiers in cancer immune biology, the role of adaptive versus innate immune mechanisms in initiating immune activation, and the development of improved in vivo models for screening therapeutic strategies.
Over the course of the two-day workshop, participants will attend five didactic sessions, each followed by an interactive panel discussion, and later split into working groups tasked with refining and prioritizing key questions identified. By contributing to defining pivotal questions in cancer immune responsiveness/resistance, participants will help deepen understanding of the cancer biology that orchestrates distinct immune landscapes, and help move the field towards improved therapeutic strategies.
Following the workshop, the SITC Cancer Immune Responsiveness Task Force will convene five working groups, incorporating workshop attendees, to address these key questions in the years ahead.
Learn more about this workshop here, and keep your eyes open for a 'registration now open' announcement coming soon.
Immuno-Oncology Biomarkers: State of the Art – May 16-17, 2018
SITC will have representation from academia, clinical medicine, government, industry and others in the cancer immunotherapy community to drive discussion during the Immuno-Oncology Biomarkers: State of the Art workshop, which runs back-to-back with the Cancer Immune Responsiveness Workshop (above).
The Immuno-Oncology Biomarkers workshop will identify the next steps for action in immunotherapy biomarker development. It will provide a forum for energetic discussion about the collaborative efforts across several societies and consortia, make progress on identification and analysis of novel biomarkers, and tackle data analysis and specimen sharing. The final session will bring together representatives from the fields of immune-oncology research, infectious disease, autoimmune disease and cell biology to discuss opportunities for cross-disciplinary collaboration to advance biomarker development.
Panel discussions following each didactic presentation will allow all participants to contribute to the conversation, and to shape the innovative collaborations, next projects and other outputs that the SITC Immune Biomarkers Task Force will incorporate over the next several years.
Learn more about this workshop here and join us to advance the conversation!
INTRODUCTORY CANCER IMMUNOTHERAPY EDUCATION NEAR YOU
Attend a regional introductory immunotherapy education program in your area and earn CME, CNE, and CPE credits. Find an Advances in Cancer Immunotherapy™ program location near you and visit our site for details about the programs and how to register.
• Feb. 9, 2018
– Durham, NC
• Feb. 24, 2018 – Charleston, SC
• March 3, 2018 – Dallas, TX
• March 10, 2018 – Miami, FL
• March 24, 2018 – Buffalo, NY